Bellerophon Therapeutics Inc - ESG Rating & Company Profile powered by AI
This Sustainability rating for Bellerophon Therapeutics Inc indicates its reporting of the UN SDGs. The assessment of Bellerophon Therapeutics Inc is assembled by All Street Sevva using proprietary artificial intelligence. Comprehensive ESG analysis of Bellerophon Therapeutics Inc can be accessed by signing up for free.
Bellerophon Therapeutics Inc in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 3.7; made up of an environmental score of 2.7, social score of 1.6 and governance score of 6.7.
3.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Analytik Jena AG | 8.0 | High |
| 1 | Adagio Therapeutics Inc | 8.0 | High |
| ... | ... | ... | |
| 107 | Dare Bioscience Inc | 3.8 | Medium |
| 107 | BARD1 Life Sciences Ltd | 3.8 | Medium |
| 110 | Bellerophon Therapeutics Inc | 3.7 | Medium |
| 110 | Dimerix Bioscience Pty Ltd | 3.7 | Medium |
| 110 | Exagen Inc | 3.7 | Medium |
| ... | ... | ... | |
| 233 | XLR Medical Corp | 0.0 | Low |
| 233 | rEVO Biologics Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Bellerophon Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Bellerophon Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Bellerophon Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Bellerophon Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Bellerophon Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Bellerophon Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Bellerophon Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Bellerophon Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with pulmonary edema from high altitude sickness. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.